EZH2 and glioblastoma: NEAT1 lncRNA is induced by the EGFR pathway in glioma which then sequesters the chromosome modification enzyme EZH2 to facilitate repression of certain target genes and to promote nuclear translocation of β-catenin, thus activating the WNT/β-catenin oncogenic pathway in GBM [99].